News - Baxter International Inc.
2012-03-12 07:00:00
On January 9th, 2012 Baxter announced it submitted a supplemental biologics license application (sBLA) to the U.S.
2012-02-10 23:35:00
On Jan 23rd, 2012, Baxter, the company manufacturing Gammagard, announced its plans to initiate second phase III trial (identical in design to the first Phase III trial) studying Gammagard Liquid
2010-12-20 11:15:00
STAMFORD, Conn., Dec. 20, 2010 /PRNewswire-USNewswire/ -- AmeriCares and Baxter International Inc. have teamed to deliver additional lifesaving intravenous (IV) solutions to Haiti as part of their ongoing effort to stem the cholera outbreak.